Reactivation of latent human cytomegaloviral infection in critically ill patients.

Background & Objectives: Human cytomegalovirus (HCMV) is a frequent participant in the infectious process in critically ill patients. This study aimed to determine the incidence of HCMV reactivation in critically ill patients and estimate the clinical effect of reactivation on the course of the pathological process.

Methods: To determine the incidence of HCMV reactivation, plasma and sputum samples were collected from 82 critically ill patients.